Baldwin Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Baldwin Investment Management's LLY Position: Q1 2026 in Review
Baldwin Investment Management reduced its Eli Lilly (LLY) stake by 0.33% in Q1 2026, selling an estimated $36.5K and leaving 10,940 shares worth $10.1M. The position accounts for 1.18% of the portfolio, ranked #9.
Baldwin Investment Management first reported a position in LLY in Q3 2020 and has held it in 23 quarters since. The position peaked at $11.8M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Baldwin Investment Management held 10,940 shares of Eli Lilly worth $10.1M as of Q1 2026.
- Baldwin Investment Management sold 36 Eli Lilly shares in Q1 2026, an estimated $36.5K.
- Eli Lilly made up 1.18% of Baldwin Investment Management's portfolio in Q1 2026, its #9 holding.
- Baldwin Investment Management first reported a position in Eli Lilly in Q3 2020 and has held it in 23 quarters since.
- Baldwin Investment Management's Eli Lilly position peaked at $11.8M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Baldwin Investment Management's 13F filing for Q1 2026, filed 12 May 2026.